Toll-like receptors (TLRs) are important for triggering innate immune responses to pathogen-associated molecular patterns in mammals. With the exception of TLR3, TLRs engage downstream signaling cascades via MyD88 to produce cytokines and chemokines and fight against pathogenic infection 1 . The mammalian TLR family consists of at least 13 members (TLR1-13). TLR7 recognizes single-stranded RNAs from RNA viruses 1 . As innate immunity has been strongly implicated in abnormal pain hypersensitivity 2 , we first examined whether thermal and mechanical pain sensitivity or pathological pain are altered in Tlr7 knockout (Tlr7 −/− ) mice.
itch sensation. We counted the number of scratches (bouts) by a hindpaw of mouse following intradermal injection of pruritogenic agents in the nape of the neck. Notably, scratches induced by histaminedependent pruritogens, such as histamine, HTMT (histamine H1 receptor agonist) and compound 48/80, which is known to release histamine from mast cells, were comparable between Tlr7 −/− and wild-type mice ( Fig. 1c and Supplementary Fig. 2a-c) . Notably, Tlr7 −/− mice showed a marked reduction in scratching behaviors in response to nonhistaminergic pruritogens, including chloroquine, an antimalaria drug 5 , and SLIGRL-NH2, an agonist of protease-activated receptor 2 ( Fig. 1c and Supplementary Fig. 2d,e) . Chloroquineinduced scratching in both sexes was reduced in Tlr7 −/− mice ( Supplementary Fig. 3a) . Notably, chloroquine induced a bell-shaped dose response curve, but scratching elicited by the highest dose (600 μg) was TLR7 independent (Supplementary Fig. 3b ). Furthermore, scratches induced by serotonin and endothelin-1 were also impaired in Tlr7 −/− mice ( Fig. 1c and Supplementary Fig. 2f,g ).
TLR7 was originally found to recognize imidazoquinoline derivatives, such as imiquimod and resiquimod (R848), and guanine analogs, such as loxoribine, all of which have anti-viral and anti-tumor properties 1, 6, 7 . Intradermal injection of imiquimod, R848 and loxoribine induced inverted U-shaped dose response curves of scratching in mice ( Fig. 2a and Supplementary Fig. 4a,b) . As expected, scratches induced by imiquimod, R848 and loxoribine were reduced in Tlr7 −/− mice ( Fig. 2b and Supplementary Figs. 2h-j and 4c,d) .
To further investigate the involvement of TLR7 in itching and pain, we used a recently developed 'cheek model' of itch 8 . The TLR7 ligands imiquimod, R848 and loxoribine all elicited itch-like scratching, but not pain-indicative wiping behavior (Supplementary Fig. 5 ), suggesting that TLR7 mediates itching rather than pain. Toll-like receptors are typically expressed in immune cells to regulate innate immunity. We found that functional Toll-like receptor 7 (TLR7) was expressed in C-fiber primary sensory neurons and was important for inducing itch (pruritus), but was not necessary for eliciting mechanical, thermal, inflammatory and neuropathic pain in mice. Our results indicate that TLR7 mediates itching and is a potential therapeutic target for antiitch treatment in skin disease conditions. Fig. 6a ) and almost abolished imiquimodinduced scratches (Fig. 2c) . Despite a marked reduction of histamineinduced scratching in Trpv1 −/− mice 10 , imiquimod-induced scratching remained unaltered (Fig. 2c) . Thus, TRPV1-expressing C fibers, but not TRPV1 per se, are required for imiquimod-elicited itching. We also tested itch responses in mast cell-deficient SASH mice 5 and found a moderate reduction (28%) in imiquimod-induced scratching (Fig. 2c) .
It is virtually unknown whether primary sensory neurons express functional TLR7. Immunohistochemistry revealed that TLR7 was mainly expressed in small-size DRG neurons ( Fig. 3a and  Supplementary Fig. 7a ). TLR7 was highly colocalized with TRPV1 and gastrin-releasing peptide (GRP), a neuropeptide that is known to elicit itch via GRP receptor expressed by spinal cord superficial dorsal horn neurons 3 (Supplementary Fig. 7b,c) . TLR7 staining was absent in DRG sections of Tlr7 −/− mice, confirming the specificity of the TLR7 antibody (Supplementary Fig. 7d) . In situ hybridization also revealed that Tlr7 mRNA was expressed in DRG neurons (Supplementary Fig. 7e ). Single-cell real-time (RT)-PCR analysis, conducted selectively in small DRG neurons, indicated that TLR7-positive population also expressed GRP and TRPV1 ( Fig. 3b and  Supplementary Fig. 8a) . Notably, the G protein-coupled receptor MrgprA3, which is known to mediate chloroquine-induced itch 5 , was colocalized with TLR7 (Fig. 3c) . In contrast, TLR8, the family member that is phylogenetically most similar to TLR7, was not expressed in adult mouse DRG (Fig. 3c and Supplementary Fig. 8a-e) .
Patch-clamp recording showed that imiquimod (20-500 μM) induced dose-dependent inward currents in capsaicin-responsive DRG neurons of wild-type, but not Tlr7 −/− , mice (Fig. 3d,e) . Imiquimod also induced action potentials in DRG neurons of wildtype, but not Tlr7 −/− , mice (Fig. 3f) . Thus, imiquimod was able to directly excite DRG neurons in a TLR7-dependent manner. R848, a dual ligand for TLR7 and TLR8, was also able to induce TLR7-dependent inward currents (Supplementary Fig. 9) .
Immunohistochemistry revealed TLR7 expression in nerve branches in the dermis and nerve terminals in the epidermis of skin tissues (Supplementary Fig. 10a-c) . RTX treatment ablated TLR7-positive fibers in the skin (Supplementary Fig. 6b,c) . We also found TLR7 in spinal cord axonal terminals (Supplementary Fig. 10d) . Thus, it is likely that TLR7 is transported from DRG cell bodies to skin nerve terminals to mediate pruritus.
In summary, we found that TLR7 mediates itch sensation, whereas all of the previously identified itch receptors are G protein-coupled receptors 3, 5, 11 . We found functional TLR7 receptors in small DRG neurons that coexpress TRPV1, GRP and MrgprA3. In particular, TLR7 is important for pruritus elicited primarily by nonhistaminergic pruritogens, although we do not exclude a partial role of TLR7 in histamine-dependent itch. Because TLR7 activation by imiquimod and R848 not only induced marked scratching, but also generated inward currents and actions potentials in DRG neurons, TLR7 ligands likely elicit itch via a direct action on sensory neurons. However, we should not rule out a role for non-neuronal cells in the skin, such as keratinocytes and mast cells, in TLR7-mediated pruritus. Notably, topical application of imiquimod, a clinically used antiviral and anti-tumor drug, frequently elicits pruritus in human 12 and also induces psoriasis-like skin inflammation in mice 13 , indicating that TLR7's role in pruritus is conserved across different species. Chronic itch is frequently associated with skin diseases and is often 14, 15 . Given its involvement in pruritus, targeting TLR7 may be promising for anti-itch treatment of skin disease.
Note: Supplementary information is available on the Nature Neuroscience website.
